Jump to:
Elana is an associate in the firm’s corporate department. She practices primarily in the firm's health care group and regularly works with the data, privacy & cybersecurity group. Elana advises a broad range of health care clients on complex regulatory, compliance, enforcement, and transactional matters.
Credentials
Education
- JD, magna cum laude, Benjamin N. Cardozo School of Law of Yeshiva University, 2019; Order of the Coif; Professor John Appel Award; Cardozo Scholars Program; Dean’s Distinguished Scholar; Managing Editor, Cardozo Law Review
- MS (Bioethics), Albert Einstein College of Medicine of Yeshiva University, 2019
- BA (Spanish & Latin American Cultures), magna cum laude, Barnard College, 2015
Admissions
New York, 2020
Publications
- Co-author, “Takeaways From New HHS Substance Use Disorder Info Rules,” Law360 (July 2, 2024)
- Co-author, “HHS Finalizes Changes with Respect to Strengthening the Privacy of Reproductive Health Care Information Under HIPAA,” Westlaw Today (May 21, 2024)
- Co-author, “HHS OCR and NIST Revamp Cybersecurity Guidance for the Health Care Industry,” Westlaw Today (March 26, 2024)
- Co-author, “Washington My Health My Data Act's Impact on Life Sciences Companies,” Bloomberg Law (March 15, 2024)
- Co-author, “Biden-Harris Administration’s Late 2023 Efforts to Enhance AI Oversight in Health Care and Life Sciences Industries Preview What Lies Ahead in 2024,” Westlaw Today (January 12, 2024)
- Co-author, “Unpacking NIST’s Guidance on Genomic Data Cybersecurity,” Law360 (January 9, 2024)
- Co-author, “New Guidance from HHS-OIG Offers Insights for Health Care Compliance Programs,” Ropes & Gray Client Alert (January 8, 2024)
- Co-author, “NIST Cybersecurity Center of Excellence – Cybersecurity of Genomic Data Report,” RopesDataPhiles (January 3, 2024)
- Author, “The 2023 AI Boom Calls for Further Regulation of the Use of AI Tools in the Health Care and Life Sciences Industries,” RopesDataPhiles (December 15, 2023)
- Co-author, “CMS Finalizes Rule Mandating Disclosures of Ownership for Nursing Facilities,” Westlaw Today (December 12, 2023)
- Co-author, “CMS Final Rule on Transparency Complicates REIT and Private Equity Company Investments in Nursing Facilities,” Ropes & Gray Alert (December 6, 2023)
- Co-author, “Raising the Floor: CMS Proposes New Nurse Staffing Requirements for Long-Term Care Facilities,” Ropes & Gray Alert (September 26, 2023)
- Co-author, “Regulation of online behavioural advertising (Part 2): existing challenges and recent changes in the United States,” Entertainment Law Review (2023)
- Co-author, “California Privacy Law Holds Implications for Mental Health Apps,” Law360 (February 1, 2023)
- Contributor, “Cybersecurity in Healthcare and Medical Devices,” chapter in Cybersecurity: A Practical Guide to the Law of Cyber Risk (2021)
- Co-author, “What Florida DNA Privacy Law Means For Health Providers,” Law360 (October 4, 2021)
- Co-author, “Recent CCPA Amendment Brings Welcome Clarifications, But Also New Obligations Around De-Identified Patient Data,” Legaltech News and Law.com (October 20, 2020)
- Co-author, “Surveying Drug Pricing Reform: The Latest Federal Activity,” Law360 (July 31, 2020)
- Co-author, “2021 Hospital IPPS/LTCH PPS Proposed Rule,” Ropes & Gray Alert (May 21, 2020)
- Co-author, “Accessing New Research Funding Opportunities During and After COVID-19,” Ropes & Gray Alert (May 7, 2020)
- Co-author, “The New Gov’t Policies Easing Deployment of Health Workers,” Law360 (April 14, 2020)
- Co-author, “Dealing with Health Care Staffing Shortages in the Face of COVID-19,” Ropes & Gray Alert (April 7, 2020)
- Co-author, “Illinois’s Expansion of Access to Health Care via Telehealth Executive Order 2020-09 & Medicaid Emergency Rulemaking,” Ropes & Gray Alert (April 6, 2020)
- Co-author, “California Bill Clarifies Privacy Law’s Ambiguities for Medical, Research Communities,” Bloomberg Law (February 13, 2020)
- Contributor, “Opioid Prescribing and Physician Autonomy: A Quality of Care Perspective,” HSS Journal (January 28, 2019)
- Author, “The Futility of Futility: An Analysis of the Charlie Gard Case Within the Framework of U.S. Law,” 40 Cardozo L. Rev. 463 (2018)
Awards
- The American Lawyer “Corporate Practice of the Year – Pharma and Health Care” (2022, 2024)